PAHC
NASDAQ · Pharmaceuticals
Phibro Animal Health Corp-A
$34.56
+0.12 (+0.33%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
-10.05%
YTD
-7.35%
Open$34.12
Previous Close$34.45
Day High$35.11
Day Low$34.12
52W High$60.08
52W Low$28.25
Volume—
Avg Volume215.9K
Market Cap1.42B
P/E Ratio14.23
EPS$2.43
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$42.00
Below
SMA 200
$35.40
Below
RSI (14)
80.2
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Sell
10 analysts
Price Target
+211.7% upside
Current
$34.56
$34.56
Target
$107.71
$107.71
$71.95
$107.71 avg
$157.72
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.48B | 1.28B | 1.31B |
| Net Income | 96.98M | 75.38M | 335.32M |
| Profit Margin | 6.6% | 6.2% | 25.7% |
| EBITDA | 239.15M | 196.21M | 482.41M |
| Free Cash Flow | — | — | 282.39M |
| Rev Growth | +15.8% | +15.8% | +2.9% |
| Debt/Equity | 1.90 | 1.90 | 0.38 |
Dividend
Dividend Yield4.55%
Annual Dividend$0.48
Payout Ratio19.5%
Frequencyquarterly
Ex-DividendApr 7, 2026
Pay DateApr 17, 2026
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |